Blackbird BioVentures
Overview
Blackbird BioVentures is a venture capital firm dedicated to fostering the growth of the life sciences sector in Baltimore and its neighboring regions. By investing in early-stage biotechnology companies, the firm aims to translate academic research into innovative commercial ventures. Their mission is to build a robust entrepreneurial ecosystem that drives job creation, retains local talent, and attracts external capital and expertise to the area. The firm focuses on various investment stages, including Pre-Seed, Seed, Series A, Series B Extension, and Post-Series A Bridge rounds. This approach allows them to support companies at different phases of development, from initial concept to scaling operations. By providing strategic guidance and capital, Blackbird BioVentures seeks to accelerate the commercialization of transformative scientific discoveries. Through its investments, Blackbird BioVentures contributes to the advancement of biotechnology, aiming to bring world-changing technologies to life and establish Baltimore as a prominent innovation hub in the life sciences field.
Investment Focus
- Early-stage biotechnology companies
- Focus on translating academic research into commercial ventures
- Located in Baltimore and surrounding regions
Reach Blackbird BioVentures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Blackbird BioVentures
What sectors does Blackbird BioVentures invest in?
Blackbird BioVentures invests in Life Sciences and Biotechnology, and is based in Maryland, United States. Blackbird BioVentures is listed as a venture capital in the ConnectSafely investor database.
What stage does Blackbird BioVentures invest at?
Blackbird BioVentures backs companies at Pre-Seed, Seed and Series A.
Which regions does Blackbird BioVentures invest in?
Blackbird BioVentures invests across United States.
Last updated · Source: ConnectSafely investor database
